Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results

BACKGROUND: Although triplet regimen of docetaxel, cisplatin, and 5-FU (DCF) reportedly yields high response rates for metastatic squamous cell carcinoma of the esophagus (SCCE), it has severe toxicity. In our previous phase II trial, grade 3/4 toxicities of neutropenia occurred in 68.8% of the pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ojima, Toshiyasu, Nakamura, Masaki, Nakamori, Mikihito, Katsuda, Masahiro, Hayata, Keiji, Kitadani, Junya, Maruoka, Shimpei, Shimokawa, Toshio, Yamaue, Hiroki
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6368232/
https://ncbi.nlm.nih.gov/pubmed/30783514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26614
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados